Evolus (EOLS) Revenue Growth (5y) (2024 - 2026)
Evolus (EOLS) Revenue Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn |
| 10 | Evolus | 406.11 Mn | 356.32 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.98% |
| Dec 31, 2025 | 34.42% |
| Sep 30, 2025 | 31.32% |
| Jun 30, 2025 | 54.80% |
| Mar 31, 2025 | 45.53% |
| Dec 31, 2024 | 32.34% |
| Sep 30, 2024 | 35.92% |
| Jun 30, 2024 | 96.04% |